An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors
Abstract Background Pancreatic cancer is one of the most difficult to treat neoplasias. Because of that, the prognosis of the disease is dismal, and identification of novel therapeutic approaches is needed. This study investigates the role of transforming growth factor-alpha (TGFα) in pancreatic can...
Saved in:
| Main Authors: | Inés Romero-Pérez, Juan Carlos Montero, Mónica Redondo-Puente, María del Carmen Gómez-García, Mireia Morell-Ginestà, Gabriel Capellá, Atanasio Pandiella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Experimental & Clinical Cancer Research |
| Online Access: | https://doi.org/10.1186/s13046-025-03421-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
by: Lucía Gandullo‐Sánchez, et al.
Published: (2020-04-01) -
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01) -
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01) -
Diverse Roles of Antibodies in Antibody–Drug Conjugates
by: Aiko Yamaguchi, et al.
Published: (2025-01-01) -
Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024-11-01)